Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Growing human skin cells in a 3D environment can stimulate new hair growth.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Mice with human skin protein K8 had more skin problems and cancer.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Surgical removal of abnormal fat pads fixed the woman's eyelid issue caused by likely silicone injections.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Apoptosis may contribute to hair loss in androgenetic alopecia.

OCT can non-invasively diagnose follicular keratosis and other hair follicle disorders.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Brassica oleracea extract, glucosinlates, and sulforaphane can boost hair growth and might be used to treat hair loss.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.